CHEMBL50378; (2R,3S)-EHNA; (2R,3S)-3-(6-aminopurin-9-yl)nonan-2-ol; (2R,3S)-3-(adenin-9-yl)-2-nonanol; (2R,3S)-9-(2-hydroxy-3-nonyl)adenine; erythro-9-(2-hydroxy-3-nonyl)adenine; (R,S)-6-amino-beta-hexyl-alpha-methyl-9H-purine-9-ethanol; EHNA.HCl; HWC 52; eh-na; Tocris-1261; (-)-erythro-9-(2-hydroxy-3-nonyl)adenine; Lopac0_000504; BSPBio_001061; KBioGR_000401; KBioSS_000401; SCHEMBL1742893; DTXSID6043880; BCBcMAP01_000066; CTK2H9386; KBio2_000401; KBio2_002969; KBio2_005537; KBio3_000761; KBio3_000762; Bio1_000430; Bio1_000919; Bio1_001408; Bio2_000361; Bio2_000841; HMS1792E03; HMS1990E03; HMS3403E03; ZINC1614354; (R-(R*,S*))-6-Amino-beta-hexyl-alpha-methyl-9H-purine-9-ethanol; BDBM50034908; CCG-36414; 9H-Purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-, (R*,S*)-(+-)-; 9H-Purine-9-ethanol, 6-amino-beta-hexyl-alpha-methyl-, (R-(R*,S*))-; SDCCGSBI-0050488.P002; 3-(6-Amino-purin-9-yl)-nonan-2-ol; IDI1_002116; SMP2_000310; NCGC00025087-01; NCGC00025087-02; NCGC00025087-03; NCGC00025087-04; NCGC00025087-05; NCGC00025087-06; NCGC00025087-08; (EHNA)3-(6-Amino-purin-9-yl)-nonan-2-ol; 3-(6-Amino-purin-9-yl)-nonan-2-ol(EHNA); (2R,3S)-3-(6-Amino-purin-9-yl)-nonan-2-ol; (2R,3S)-3-(6-Amino-9H-purine-9-yl)2-nonanol; (2R,3S)-3-((R)-6-Amino-purin-9-yl)-nonan-2-ol; BRD-K27450477-001-03-9; (2R,3S)-rel-3-(6-Amino-9H-purin-9-yl)nonan-2-ol